Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - a review. (Q36497543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16754269%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

review article

1 reference

title

Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16754269%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16754269%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Dag Elmfeldt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16754269%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16754269%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16754269%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16754269%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16754269%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

71-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16754269%20AND%20SRC:MED&resulttype=core&format=json

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

Study on COgnition and Prognosis in the Elderly (SCOPE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

The Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

New-onset diabetes and antihypertensive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050600771583

10.1080/08037050600771583

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16754269%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference